These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 26468135)
1. Fluctuations of Hyperglycemia and Insulin Sensitivity Are Linked to Menstrual Cycle Phases in Women With T1D. Brown SA; Jiang B; McElwee-Malloy M; Wakeman C; Breton MD J Diabetes Sci Technol; 2015 Oct; 9(6):1192-9. PubMed ID: 26468135 [TBL] [Abstract][Full Text] [Related]
2. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414 [TBL] [Abstract][Full Text] [Related]
3. Performance of the MiniMed 780G system on mitigating menstrual cycle-dependent glycaemic variability. Elhenawy YI; Abdel Kader MS; Thabet RA Diabetes Obes Metab; 2024 Nov; 26(11):4916-4923. PubMed ID: 39248215 [TBL] [Abstract][Full Text] [Related]
4. Menstrual cycle effects on insulin sensitivity in women with type 1 diabetes: a pilot study. Trout KK; Rickels MR; Schutta MH; Petrova M; Freeman EW; Tkacs NC; Teff KL Diabetes Technol Ther; 2007 Apr; 9(2):176-82. PubMed ID: 17425444 [TBL] [Abstract][Full Text] [Related]
5. Stress Testing of an Artificial Pancreas System With Pizza and Exercise Leads to Improvements in the System's Fuzzy Logic Controller. Mauseth R; Lord SM; Hirsch IB; Kircher RC; Matheson DP; Greenbaum CJ J Diabetes Sci Technol; 2015 Sep; 9(6):1253-9. PubMed ID: 26370244 [TBL] [Abstract][Full Text] [Related]
6. Insulin Replacement Across the Menstrual Cycle in Women with Type 1 Diabetes: An In Silico Assessment of the Need for Ad Hoc Technology. Diaz C JL; Fabris C; Breton MD; Cengiz E Diabetes Technol Ther; 2022 Nov; 24(11):832-841. PubMed ID: 35714349 [No Abstract] [Full Text] [Related]
7. Alterations in glucose metabolism during menstrual cycle in women with IDDM. Widom B; Diamond MP; Simonson DC Diabetes Care; 1992 Feb; 15(2):213-20. PubMed ID: 1547678 [TBL] [Abstract][Full Text] [Related]
8. [Glycemic changes during menstrual cycles in women with type 1 diabetes]. Herranz L; Saez-de-Ibarra L; Hillman N; Gaspar R; Pallardo LF Med Clin (Barc); 2016 Apr; 146(7):287-91. PubMed ID: 26897501 [TBL] [Abstract][Full Text] [Related]
9. Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy. Polsky S; Giordano D; Voelmle MK; Garcetti R; Garg SK Postgrad Med; 2016 May; 128(4):418-26. PubMed ID: 26924774 [TBL] [Abstract][Full Text] [Related]
10. Continuous Glucose Monitors and Activity Trackers to Inform Insulin Dosing in Type 1 Diabetes: The University of Virginia Contribution. Fabris C; Ozaslan B; Breton MD Sensors (Basel); 2019 Dec; 19(24):. PubMed ID: 31817678 [No Abstract] [Full Text] [Related]
11. Impact of an Advanced Hybrid Closed-Loop System on Glycemic Control Throughout the Menstrual Cycle in Women with Type 1 Diabetes Prone to Hypoglycemia. Mesa A; Solà C; Vinagre I; Roca D; Granados M; Pueyo I; Cabré C; Conget I; Giménez M Diabetes Technol Ther; 2024 Sep; 26(9):667-672. PubMed ID: 38441905 [TBL] [Abstract][Full Text] [Related]
12. Diabetes technology and treatments in the paediatric age group. Shalitin S; Peter Chase H Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816 [TBL] [Abstract][Full Text] [Related]
13. Physical Activity Capture Technology With Potential for Incorporation Into Closed-Loop Control for Type 1 Diabetes. Dadlani V; Levine JA; McCrady-Spitzer SK; Dassau E; Kudva YC J Diabetes Sci Technol; 2015 Oct; 9(6):1208-16. PubMed ID: 26481641 [TBL] [Abstract][Full Text] [Related]